Abstract:Key PointsThe motility of both tumour and normal host cells contributes to tumour metastasis at several steps, including breaching of basement membrane, escape from the primary tumour, migration to blood and lymphatic vessels, intravasation and extravasation and movement into distant organs. The ability to migrate towards favourable environments is a fundamental and evolutionarily conserved cellular behaviour from unicellular organisms to humans.Both normal and cancer cells migrate using diverse modes including amoeboid, mesenchymal, epithelial, collective and individual. Simple model organisms also exhibit these diverse modes of motility and offer experimental advantages such as low cost, amenability to large-scale genetic and pharmacological screening and live imaging of cells interacting within their native environments.Studies of the social amoeba Dictyostelium discoideum have unravelled the complex signalling networks that mediate chemokine-directed cell migration, which is also observed with human immune and tumour cells.The combination of high-resolution live imaging and genetic screening in the nematode has revealed that cells can breach a basement membrane by pushing the matrix aside and also by degrading it. This potentially offers a new mechanism to target cancer invasion therapeutically.Cooperative, collective cell motility appears to contribute to tumour metastasis. Border cells in the Drosophila melanogaster ovary serve as a simple model that is genetically tractable and amenable to live imaging. This model has revealed that some mechanisms of cooperative, collective cell migration, such as the requirement for E-cadherin, differ from those of single-cell motility.Direct modelling of metastasis can be carried out in both flies and fish. Work in flies has resulted in the identification and optimization of kinase inhibitors for metastatic thyroid cancer. The fish offers the lowest-cost vertebrate model for intravasation and extravasation studies and is amenable to live imaging as well as genetic and pharmacological manipulation.

Using Drosophila to uncover the role of organismal physiology and the tumor microenvironment in cancer

Drosophila melanogaster: A Model Organism to Study Cancer

Metabolic Adaptations in Cancer and the Host Using Drosophila Models and Advanced Tools

Tumor models in various Drosophila tissues

A Blueprint for Cancer-Related Inflammation and Host Innate Immunity

Dissecting Social Cell Biology and Tumors Using Drosophila Genetics.

Drosophila Larval Models of Invasive Tumorigenesis for In Vivo Studies on Tumour/Peripheral Host Tissue Interactions during Cancer Cachexia

Cell motility in cancer invasion and metastasis: insights from simple model organisms

Understanding organotropism in cancer metastasis using microphysiological systems

Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis

Orthotopic and metastatic tumour models in preclinical cancer research

Dissecting metastasis using preclinical models and methods

Emerging In Vitro and In Vivo Models: Hope for the Better Understanding of Cancer Progression and Treatment

State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?

Oncogenic Pathways and Loss of the Rab11 GTPase Synergize To Alter Metabolism in Drosophila.

Metastasis Organotropism: Redefining the Congenial Soil

Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases

Organotropism: new insights into molecular mechanisms of breast cancer metastasis

One hundred years of Drosophila cancer research: no longer in solitude

Mechanistic characterization of a Drosophila model of paraneoplastic nephrotic syndrome

Disruption of Lysosome Function Promotes Tumor Growth and Metastasis in Drosophila